Investigational Site Number :3920004

Bunkyo-ku, Tokyo 113-8519

0 studies enrolling now · 1 studies all time

What they study most

Neurodermatitis

Studies at this site

• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME) — Completed